Is cancer an autoimmune process dependent on anti-apoptotic autoantibodies?
Abstract
Dysregulated apoptosis is a potentially important mechanism in the pathogenesis of cancer. Autoantibodies, which inhibit apoptosis, have recently been identified in patients with malignant diseases. We suggest that such inhibitory autoantibodies participate in tumorigenesis. These views may provide a basis for the increased incidence of cancer in patients with autoimmune diseases and have novel therapeutic implications for cancer.
No full text is available. To read the body of this article, please view the PDF online.
To access this article, please choose from the options below
PII: S0306-9877(99)91035-6
doi:10.1054/mehy.1999.1035
© 2000 Harcourt Publishers Ltd. All rights reserved.
